Quantitative cerebral blood flow determinations in acute ischemic stroke. Relationship to computed tomography and angiography.

BACKGROUND AND PURPOSE The advent of new modalities to treat acute ischemic stroke presents the need for accurate, early diagnosis. In acute ischemic stroke, CT scans are frequently normal or reveal only subtle hypodense changes. This study explored the utility and increased sensitivity of xenonenhanced CT (XeCT) in the diagnosis of acute cerebral ischemia and investigated the relationship between cerebral blood flow (CBF) measurements and early CT and angiographic findings in acute stroke. METHODS The CT scans, XeCT scans, and angiograms of 20 patients who presented within 6 hours of acute anterior circulation ischemic strokes were analyzed. RESULTS CT scans were abnormal in 11 (55%) of 20 patients. XeCT scans were abnormal in all 20 (100%) patients, showing regions of interest with CBF < 20 (mL/100 g per minute) in the symptomatic middle cerebral artery (MCA) territories. The mean CBF in the symptomatic MCA territories was significantly lower than than of the asymptomatic MCA territories (P < .0005). In patients with basal ganglia hypodensities, the mean symptomatic MCA territory CBF was significantly lower than that of patients who did not exhibit these early CT findings (P < .05). The mean symptomatic MCA territory CBF in patients with angiographic M1 occlusions was significantly lower than that of patients whose infarcts were caused by MCA branch occlusions (P < .01). CONCLUSIONS These results show that XeCT is more sensitive than CT in detecting acute strokes and that CBF measurements correlate with early CT and angiographic findings. XeCT may allow for the hyperacute identification of subsets of patients with acute ischemic events who are less likely to benefit and more likely to derive complications from aggressive stroke therapy.

[1]  S. Nakano,et al.  Prediction of hemorrhagic complications after thrombolytic therapy for middle cerebral artery occlusion: value of pre- and post-therapeutic computed tomographic findings and angiographic occlusive site. , 1996, Neurosurgery.

[2]  M. Hommel,et al.  Thrombolytic therapy with streptokinase in acute ischemic stroke. , 1996, The New England journal of medicine.

[3]  T. L. Davis,et al.  Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging. , 1996, Radiology.

[4]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[5]  M. Kaste,et al.  Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.

[6]  M Fisher,et al.  New magnetic resonance techniques for acute ischemic stroke. , 1995, JAMA.

[7]  K. Woods Mega-trials and management of acute myocardial infarction , 1995, The Lancet.

[8]  B. Siewert,et al.  Acute human stroke studied by whole brain echo planar diffusion‐weighted magnetic resonance imaging , 1995, Annals of neurology.

[9]  K. Lees,et al.  Termination of trial of streptokinase in severe acute ischaemic stroke , 1995, The Lancet.

[10]  M Hoehn-Berlage,et al.  Diffusion and perfusion MR imaging of cerebral ischemia. , 1995, Cerebrovascular and brain metabolism reviews.

[11]  J. Broderick,et al.  Factors Related to Intracranial Hematoma Formation in Patients Receiving Tissue‐Type Plasminogen Activator forAcute Ischemic Stroke , 1994, Stroke.

[12]  R. V. Van Heertum,et al.  The role of single photon emission computed tomography brain imaging with 99mTc-bicisate in the localization and definition of mechanism of ischemic stroke. , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  W Hacke,et al.  Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. , 1994, AJNR. American journal of neuroradiology.

[14]  J. Broderick,et al.  Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group. , 1993, Stroke.

[15]  G. Marchal,et al.  PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome , 1993, The Lancet.

[16]  J. Marler,et al.  Urgent Therapy for Stroke: Part II. Pilot Study of Tissue Plasminogen Activator Administered 91-180 Minutes From Onset , 1992, Stroke.

[17]  J. Broderick,et al.  Urgent Therapy for Stroke: Part I. Pilot Study of Tissue Plasminogen Activator Administered Within 90 Minutes , 1992, Stroke.

[18]  J. Broderick,et al.  Thrombus localization with emergency cerebral CT. , 1992, AJNR. American journal of neuroradiology.

[19]  H. Yonas,et al.  Xe/CT cerebral blood flow evaluation of delayed symptomatic cerebral ischemia after subarachnoid hemorrhage. , 1992, AJNR. American journal of neuroradiology.

[20]  H Yonas,et al.  CBF Measured by Xe-CT: Approach to Analysis and Normal Values , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  R N Bryan,et al.  Diagnosis of Acute Cerebral Infarction : Comparison of CT and MR Imaging 611 , 2013 .

[22]  D. Gur,et al.  Xenon-enhanced CT of the brain: effect of flow activation on derived cerebral blood flow measurements. , 1991, AJNR. American journal of neuroradiology.

[23]  C. Truwit,et al.  Loss of the insular ribbon: another early CT sign of acute middle cerebral artery infarction. , 1990, Radiology.

[24]  D. Gur,et al.  Stable xenon-enhanced CT measurement of cerebral blood flow in reversible focal ischemia in baboons. , 1990, Journal of neurosurgery.

[25]  C. Pozzilli,et al.  Predictive value of brain perfusion single-photon emission computed tomography in acute ischemic stroke. , 1990, Stroke.

[26]  L Bozzao,et al.  Correlation of angiographic and sequential CT findings in patients with evolving cerebral infarction. , 1989, AJNR. American journal of neuroradiology.

[27]  David Gur,et al.  Determination of irreversible ischemia by xenon-enhanced computed tomographic monitoring of cerebral blood flow in patients with symptomatic vasospasm. , 1989, Neurosurgery.

[28]  F. Shishido,et al.  Early CT finding in cerebral infarction: obscuration of the lentiform nucleus. , 1988, Radiology.

[29]  A. Yamadori,et al.  Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. , 1988, Stroke.

[30]  D. Gur,et al.  Stable xenon enhanced computed tomography in the study of clinical and pathologic correlates of focal ischemia in baboons. , 1988, Stroke.

[31]  J. Thompson,et al.  An early CT sign of ischemic infarction: increased density in a cerebral artery. , 1987, AJR. American journal of roentgenology.

[32]  R. Okeda,et al.  Discrepancies among CT, histological, and blood-brain barrier findings in early cerebral ischemia. , 1986, Journal of neurosurgery.

[33]  David Gur,et al.  In vivo mapping of local cerebral blood flow by xenon-enhanced computed tomography. , 1982, Science.

[34]  R. Ojemann,et al.  Thresholds of focal cerebral ischemia in awake monkeys. , 1981, Journal of neurosurgery.

[35]  J. Halsey,et al.  Sensitivity of rCBF to Focal Lesions , 1981, Stroke.